Page last updated: 2024-08-16

sulfinpyrazone and sulfadiazine

sulfinpyrazone has been researched along with sulfadiazine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (57.14)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Anton, AH	1

Reviews

1 review(s) available for sulfinpyrazone and sulfadiazine

Article	Year
Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review. Annals of the New York Academy of Sciences, 1973, Nov-26, Volume: 226 Topics: Abnormalities, Drug-Induced; Blood Proteins; Drug Synergism; Escherichia coli; Female; Fetus; Humans; Infant, Newborn; Kinetics; Maternal-Fetal Exchange; Phenylbutazone; Pregnancy; Protein Binding; Serum Albumin; Sulfadiazine; Sulfamethoxypyridazine; Sulfathiazoles; Sulfinpyrazone; Sulfisoxazole; Sulfonamides	1973

Article

Year

Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.

Annals of the New York Academy of Sciences, 1973, Nov-26, Volume: 226

Topics: Abnormalities, Drug-Induced; Blood Proteins; Drug Synergism; Escherichia coli; Female; Fetus; Humans; Infant, Newborn; Kinetics; Maternal-Fetal Exchange; Phenylbutazone; Pregnancy; Protein Binding; Serum Albumin; Sulfadiazine; Sulfamethoxypyridazine; Sulfathiazoles; Sulfinpyrazone; Sulfisoxazole; Sulfonamides

1973

Other Studies

6 other study(ies) available for sulfinpyrazone and sulfadiazine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Identification and prediction of promiscuous aggregating inhibitors among known drugs. Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21 Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship	2003
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010